Strides Shasun shines on planning to launch Ranitidine OTC Tablets in US markets

26 Feb 2018 Evaluate

Strides Shasun is currently trading at Rs. 712.90, up by 20.00 points or 2.89% from its previous closing of Rs. 692.90 on the BSE.

The scrip opened at Rs. 697.85 and has touched a high and low of Rs. 714.95 and Rs. 693.80 respectively. So far 18795 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1194.00 on 27-Feb-2017 and a 52 week low of Rs. 640.65 on 06-Feb-2018.

Last one week high and low of the scrip stood at Rs. 741.05 and Rs. 681.00 respectively. The current market cap of the company is Rs. 6354.50 crore.

The promoters holding in the company stood at 31.36%, while Institutions and Non-Institutions held 51.68% and 16.95% respectively.

Strides Shasun will launch Ranitidine Tablets USP, 150 mg (OTC) in the US markets. The company is already a key player in the US Ranitidine Rx market with 32% market share through its approval for Ranitidine Tablets USP, 150 mg and 300 mg. The new launch will further strengthen the company’s Ranitidine franchise. According to IRI data, the US OTC market for Ranitidine Tablets, which is the generic form of the popular brand Zantac, is around $200 million.

This is the first product approval from the company’s 50:50 JV with Vivimed Labs. The product will be backward integrated and will be manufactured at the JV’s Oral dosage facility in Chennai. Strides will have exclusive marketing rights for the product in the US. The product will be launched immediately.

The company has 82 cumulative ANDA filings with USFDA (including its JV with Vivimed) of which 50 ANDAs have been approved as of date and 32 are pending approval.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×